Salix Pharmaceuticals Falls 15%, Progenics Falls 40% Pre-Market Following Receipt of CRL from FDA
Get News First. Profit Faster
With Benzinga Professional get unlimited access to ALL content! PLUS:
- REALTIME NEWSFEED
- REALTIME AUDIO NEWS
- FULL CALENDAR SUITE
- CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS
FirstEnergy Capital Upgrades Enerplus from Market Perform to Outperform, Announces PT of $18
06:26am - November 12, 2012Clarkson Capital Markets Upgrades Transocean from Market Perform to Outperform, Raises PT from $55 to $59
06:15am - November 12, 2012Citigroup Upgrades Walt Disney from Neutral to Buy, Raises PT from $50 to $54
06:14am - November 12, 2012
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted in: News, FDA, Pre-Market Outlook, Movers
Advertisement
Advertisement
